Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

Bortezomib (Btz) is an active agent used to treat multiple myeloma (MM). Not all patients who receive Btz-containing therapy show a favorable response. Interaction of cellular adhesion molecules with MM and bone marrow stromal cells is crucial for the survival of MM cells. However, little is known a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Takashi, Ri, Masaki, Kinoshita, Shiori, Narita, Tomoko, Totani, Haruhito, Ashour, Reham, Ito, Asahi, Kusumoto, Shigeru, Ishida, Takashi, Komatsu, Hirokazu, Iida, Shinsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940221/
https://www.ncbi.nlm.nih.gov/pubmed/29738534
http://dx.doi.org/10.1371/journal.pone.0196780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940221/
https://www.ncbi.nlm.nih.gov/pubmed/29738534
http://dx.doi.org/10.1371/journal.pone.0196780

Ejemplares similares